| Basics |
BeyondSpring Inc. Ordinary Shares
BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies.
|
| IPO Date: |
March 9, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$70.95M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.40 | 3.63%
|
| Avg Daily Range (30 D): |
$0.07 | 4.54%
|
| Avg Daily Range (90 D): |
$0.06 | 3.69%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.26M |
| Avg Daily Volume (30 D): |
.01M |
| Avg Daily Volume (90 D): |
.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
145 |
| Avg Trade Size (Sh.) (30 D): |
306 |
| Avg Trade Size (Sh.) (90 D): |
237 |
| Institutional Trades |
| Total Inst.Trades: |
118 |
| Avg Inst. Trade: |
$1.43M |
| Avg Inst. Trade (30 D): |
$1.04M |
| Avg Inst. Trade (90 D): |
$1.04M |
| Avg Inst. Trade Volume: |
.1M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.68M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
149.69K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.09
|
$.11
|
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ M
|
$ M
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -12.24M
|
$ 1.17M
|
$
|
|
Operating Income / Loss
|
$ -9.31M
|
$ -2.61M
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 3.6M
|
$ M
|
$
|
|
PE Ratio
|
|
|
|
|
